skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?

(2257) Views  (400) Full article downloads

Authors: Ramesh Mazhari, Judith Hsia

Published Date January 2005 Volume 2005:1(2) Pages 111 - 117
DOI: http://dx.doi.org/10.2147/VHRM.S

Ramesh Mazhari, Judith Hsia

Division of Cardiology, George Washington University, Washington, DC, USA

Abstract: Peripheral arterial disease (PAD), like coronary heart disease, is a clinical manifestation of atherosclerosis and is associated with increased mortality. Although atherosclerotic cardiovascular disease is the leading cause of death for women as well as for men, PAD in women has received less attention than coronary heart disease or stroke. This paper reviews the prevalence of PAD, its risk factors, clinical significance, and management in women. One gender-specific therapeutic issue of particular interest to practitioners and the lay public is the role of postmenopausal hormone therapy. Prior to completion of the Heart and Estrogen/Progestin Replacement Study and the Women’s Health Initiative Hormone Trials, postmenopausal hormone therapy was believed to exert antiatherosclerotic effects and to thereby reduce coronary heart disease risk in women on the basis of case-control and cohort studies. This review particularly focuses on the role, if any, of postmenopausal hormone therapy for prevention or treatment of PAD, which was a pre-specified secondary outcome for these three randomized trials.

Keywords: women, estrogen, peripheral arterial disease






Readers of this article also read:

Relationship between arterial stiffness and heart rate recovery in apparently healthy adults
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome
Epidemiology, classification, and modifiable risk factors of peripheral arterial disease
Pupillography of automated swinging flashlight test in amblyopia
Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University